Prescription for Excellence - the future of pharmaceutical care: vision and plan

Appendix 1- Drivers for Change

The Wilson and Barber Review was commissioned by Nicola Sturgeon MSP, Cabinet Secretary for Health, Wellbeing and Cities Strategy in October 2011. The findings from this and other reports and studies have provided the evidence to support the Vision NHS Pharmaceutical Care for the future. The main drivers for change are listed below:

• Ambitions of 20:20 Vision - Achieving Sustainable Quality in Scotland's Healthcare: A 20:20 Vision 2011, Scottish Government, September 2011.
• A Route Map to the 2020 Vision for Health and Social care, Scottish Government, March 2013.
• Healthcare Quality Strategy for NHSScotland - The Healthcare Quality Strategy for NHSScotland, Scottish Government, May 2010.
• NHS healthcare as a whole is changing and needs to evolve to meet demographic changes, the associated changes in morbidity and continuing health inequalities.
• Continuity of care was expressed as an important issue by the patient group.
• Integration of health and social care
• Desire to treat patients in their own homes/communities where possible
• Evolution of therapeutics and new types of medicines e.g. stratified medicines
• Desire for Scotland to be a leader in healthcare/patient safety/research
• Increase in multi-morbidity and co-morbidity and resulting complex needs
• Focus on adherence/non-compliance
• eHealth Person-Centred Strategy.^[35]